Insider · CIK 0002050167

Dandekar Atul

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0002050167

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	39,816
2026-09-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,500 sh	$27.06	−$203K	32,316
2026-09-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	6,643
2026-09-03	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−3,207 sh	$26.01	−$83.4K	32,352
2026-09-03	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−36 sh	$25.81	−$929.16	32,316
2026-09-02	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−2,800 sh	$26.38	−$73.9K	35,950
2026-09-02	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−391 sh	$27.12	−$10.6K	35,559
2026-09-01	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+12.5K sh	—	—	38,750
2026-09-01	MAZEMaze Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CSBO	MExercise/Conversion	−12.5K sh	—	—	12,500
2026-08-28	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	33,750
2026-08-28	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,500 sh	$27.58	−$207K	26,250
2026-08-28	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	14,143
2026-07-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	33,750
2026-07-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,100 sh	$27.31	−$194K	26,650
2026-07-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−400 sh	$27.89	−$11.2K	26,250
2026-07-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	21,643
2026-06-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	33,750
2026-06-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,500 sh	$28.02	−$210K	26,250
2026-06-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	29,143
2026-05-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	32,308
2026-05-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,500 sh	$26.34	−$198K	24,808
2026-05-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	36,643
2026-05-04	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+8,320 sh	$10.42	+$86.7K	18,823
2026-05-04	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+5,985 sh	$10.42	+$62.4K	24,808
2026-05-04	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−8,320 sh	—	—	20,204
2026-05-04	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−5,985 sh	—	—	27,725
2026-04-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	18,003
2026-04-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−7,500 sh	$25.37	−$190K	10,503
2026-04-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	44,143
2026-03-30	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	18,003
2026-03-30	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−6,710 sh	$29.26	−$196K	11,293
2026-03-30	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−790 sh	$30.02	−$23.7K	10,503
2026-03-30	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	51,643
2026-03-02	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CSBO	AAward	+38K sh	—	—	38,000
2026-03-02	MAZEMaze Therapeutics, Inc. · Restricted Stock UnitsA Award	CSBO	AAward	+19K sh	—	—	19,000
2026-02-27	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	18,003
2026-02-27	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−3,739 sh	$45.13	−$169K	14,264
2026-02-27	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−3,761 sh	$45.72	−$172K	10,503
2026-02-27	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	59,143
2026-01-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+7,500 sh	$10.42	+$78.2K	18,003
2026-01-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−1,200 sh	$43.18	−$51.8K	16,803
2026-01-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−3,500 sh	$44.04	−$154K	13,303
2026-01-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−2,800 sh	$45.01	−$126K	10,503
2026-01-29	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−7,500 sh	—	—	66,643
2025-12-30	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+100 sh	$10.42	+$1,042	10,603
2025-12-30	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−100 sh	$40.36	−$4,036	10,503
2025-12-30	MAZEMaze Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSBO	MExercise/Conversion	−100 sh	—	—	74,143
2025-12-29	MAZEMaze Therapeutics, Inc.M Exercise/Conversion	CSBO	MExercise/Conversion	+72.4K sh	$10.42	+$754K	82,903
2025-12-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−66.4K sh	$40.51	−$2.69M	16,538
2025-12-29	MAZEMaze Therapeutics, Inc.S Sale	CSBO	SSale	−6,035 sh	$41.13	−$248K	10,503

Recent filings

Accepted (ET)
Oct 14
Dandekar Atul0002050167-26-000030
SEC(opens sec.gov)
Sep 44
Dandekar Atul0002050167-26-000027
SEC(opens sec.gov)
Sep 34
Dandekar Atul0002050167-26-000025
SEC(opens sec.gov)
Aug 314
Dandekar Atul0002050167-26-000023
SEC(opens sec.gov)
Jul 314
Dandekar Atul0002050167-26-000019
SEC(opens sec.gov)
Jul 14
Dandekar Atul0002050167-26-000016
SEC(opens sec.gov)
Jun 24
Dandekar Atul0002050167-26-000013
SEC(opens sec.gov)

Companies

Maze Therapeutics, Inc.CSBOMAZE

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080